Summary

for people ages 18 years and up (full criteria)
at San Francisco, California
study started
Jane Koehler

Description

Summary

Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).

Keywords

Leishmaniasis, CutaneousLeishmaniasis, MucocutaneousNew World Cutaneous or Mucocutaneous LeishmaniasisLeishmaniasisAntimony Sodium Gluconatesodium stibogluconate (Pentostam)

Eligibility

You can join if…

Open to people ages 18 years and up

  • Biopsy proven new world cutaneous or mucocutaneous leishmania

You CAN'T join if...

  • Prolonged QT
  • Liver disease
  • Pancreatitis

Location

  • University of CA at San Francisco Hospitals and Clinics
    San FranciscoCalifornia94143United States

Lead Scientist

  • Jane Koehler
    Research in my laboratory is focused on defining the clinical spectrum, microbiology, and molecular pathogenesis of the emerging pathogen Bartonella. Our research encompasses both translational and basic investigation. B. henselae and B.

Details

Status
accepting new patients by invitation only
Start Date
Sponsor
University of California, San Francisco
ID
NCT00508963
Study Type
Expanded Access
Last Updated